The clinical implications of triple therapy in fixed-dose combination in COPD: from the trial to the patient.

MLA

López-Campos, José Luis, et al. “The Clinical Implications of Triple Therapy in Fixed-Dose Combination in COPD: From the Trial to the Patient.” Archivos de Bronconeumología (English Edition), vol. 56, no. 4, Apr. 2020, pp. 242–48. EBSCOhost, https://doi.org/10.1016/j.arbr.2020.02.002.

APA

López-Campos, J. L., Carrasco-Hernández, L., Román Rodríguez, L., Quintana-Gallego, E., Carmona Bernal, C., & Alcázar Navarrete, B. (2020). The clinical implications of triple therapy in fixed-dose combination in COPD: from the trial to the patient. Archivos de Bronconeumología (English Edition), 56(4), 242–248. https://doi.org/10.1016/j.arbr.2020.02.002

Chicago

López-Campos, José Luis, Laura Carrasco-Hernández, Lucas Román Rodríguez, Esther Quintana-Gallego, Carmen Carmona Bernal, and Bernardino Alcázar Navarrete. 2020. “The Clinical Implications of Triple Therapy in Fixed-Dose Combination in COPD: From the Trial to the Patient.” Archivos de Bronconeumología (English Edition) 56 (4): 242–48. doi:10.1016/j.arbr.2020.02.002.